Most read articles by the same author(s)
- Sanja Stanisic, Americo Cicchetti, Camillo Porta, Giuseppe Procopio, Patrizia Berto, Cost-effectiveness of cabozantinib in second-line treatment of metastatic renal cell cancer (mRCC) in Italy , Global and Regional Health Technology Assessment: Vol. 5 No. 1 (2018): January-December 2018
- Michela Bobini, Eugenio Di Brino, Americo Cicchetti, Towards a Green Health Technology Assessment: embedding Life Cycle Assessment for sustainable choices , Global and Regional Health Technology Assessment: Vol. 12 No. 1 (2025): January-December 2025
- Francesco S. Mennini, Lara Gitto, Roberto Scrivo, Filippo Drago, Marco Iezzi, Lorenzo Terranova, Matteo Ruggeri, Andrea Marcellusi, Simone Russo, Raffaella Viti, Americo Cicchetti, The Promotion of Drug Innovation in Italy: Critical Aspects and Unsolved Problems , Global and Regional Health Technology Assessment: Vol. 3 No. 1 (2016): January-April 2016
- Americo Cicchetti, Silvia Coretti, Daniele Mascia, Nicola Mazzanti, Pietro Refolo, Francesca R. Rolli, Filippo Rumi, Assessing social and economic impact of subcutaneous mAbs in oncology , Global and Regional Health Technology Assessment: Vol. 5 No. 1 (2018): January-December 2018
- Matteo Ruggeri, Andrea Aiello, Anna D’Ausilio, Eugenio Di Brino, Salvatore Cottone, Angelo Ghezzi, Lorella Lombardozzi, Alessandra Mecozzi, Dario Sacchini, Alessandro Roccia, Monica Mangone, Mondher Toumi, Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple Sclerosis , Global and Regional Health Technology Assessment: Vol. 3 No. 3 (2016): September-December 2016
- Francesco Saverio Mennini, Andrea Marcellusi, Patrizia Giannantoni, Stefano Valente, Alessandro Rinaldi, Elisabetta Franco, Budget impact of pneumococcal vaccination in adults and elderly in Italy , Global and Regional Health Technology Assessment: Vol. 2 No. 1 (2015): January-April 2015
- Chiara Bini, Andrea Marcellusi, Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Molinari, Paolo Morelli, Stanimira Krotneva, Shujun Li, Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy , Global and Regional Health Technology Assessment: Vol. 11 No. 1: January-December 2024
- Francesco Saverio Mennini, Andrea Marcellusi, Raffaella Viti, Massimo Andreoni, Willingness to pay for innovation: the case of the anti-HCV drugs from the Italian National Health Service perspective , Global and Regional Health Technology Assessment: Vol. 2 No. 2 (2015): May-August 2015
- Paola Codella, Silvia Coretti, Alessandra Fiore, Giuliano Rizzardini, Matteo Ruggeri, Cost-Effectiveness Studies in HIV Treatment with Lopinavir/Ritonavir: A Review , Global and Regional Health Technology Assessment: Vol. 1 No. 2 (2014): July-December 2014
- Andrea Marcellusi, Luca Bianchi, Antonio Gasbarrini, Guido Valesini, Francesco Saverio Mennini, Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanercept , Global and Regional Health Technology Assessment: Vol. 4 No. 1 (2017): January-December 2017